A Phase 2 Trial of MLN8237 in Adult Patients With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome

This study has been completed.

Study NCT00830518 Information provided by Millennium Pharmaceuticals, Inc.

First Received: January 27, 2009 Last Updated: January 26, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2011
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: January 26, 2012